ACORN CAPITAL ADVISORS, LLC is a Venture Capital based in New York, NY led by Anthony Michael Gallo, reporting $239.2M in AUM as of Q3 2025 with 90% Healthcare concentration, 88% concentrated in top 10 holdings, and 23% allocation to CGON.
Largest long holdings in ACORN CAPITAL ADVISORS, LLC's portfolio (87.7% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $45.6M | 23.14% | — | 1.48% 1.1M shares | |
Biotechnology Healthcare | $25.1M | 12.76% | — | 2.72% 1.3M shares | |
Biotechnology Healthcare | $21.9M | 11.14% | — | 8.20% 4.1M shares | |
Biotechnology Healthcare | $19.6M | 9.96% | — | 1.76% 2.1M shares | |
Biotechnology Healthcare | $14.8M | 7.52% | — | 2.25% 2.0M shares | |
Biotechnology Healthcare | $13.2M | 6.68% | — | 4.70% 2.6M shares | |
Unknown Unknown | $10.2M | 5.16% | — | 1.18% 643.4K shares | |
Unknown Unknown | $7.8M | 3.96% | — | 20.99% 2.8M shares | |
Biotechnology Healthcare | $7.6M | 3.87% | — | 4.54% 1.8M shares | |
Biotechnology Healthcare | $6.9M | 3.49% | — | 1.27% 779.5K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in ACORN CAPITAL ADVISORS, LLC's latest filing
| Position | Shares Δ |
|---|---|
New | |
+77.81% | |
+39.28% |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
-20.36% |
Portfolio insights and performance metrics for ACORN CAPITAL ADVISORS, LLC
We use cookies for analytics. See our Privacy and Cookie Policy.